Lupin’s Generic Health acquires Southern Cross Pharma in Australia
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
CII to work with Serum Institute of India to expand vaccination across small towns and rural areas
As part of the pan-India vaccine-demand aggregation exercise, CII undertook a survey with response from over 3,000 companies in…
ISPE publishes ISPE APQ Guide: Management Responsibilities and Management Review
This is the second publication in the APQ Guide series that seeks to improve the state of pharmaceutical quality and ensure…
Alkem Laboratories says US FDA inspection at Taloja facility ends with ‘zero’…
At the end of the inspection, no form 483 was issued, the company said
After suspending EUA request, Brazil now shelves import authorisation of Covaxin
According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa, its Collegiate Board recently took a…
FDA accepts application for Roche’s Faricimab
If approved, Faricimab would be the first and only medicine designed to target two distinct pathways that drive retinal diseases…
White paper calls for action on AMR
It is already estimated that by 2050, 10 million deaths can be attributed to AMR
NPPA fixes ceiling prices of 355 medicines and 882 formulations
The authority fixes the ceiling prices of scheduled formulations as per the provisions of DPCO, 2013, and monitors the prices of…
Private equity firms acquiring top CMOs at a rapid rate: GlobalData
GlobalData’s report states that PE-backed CMOs will find they have a lot more financial support to add to their service offerings…
Biocon Biologics and Viatris receive US FDA approval for maiden interchangeable biosimilar Semglee
Interchangeable designation allows substitution at the pharmacy counter for Lantus across the US to help increase access to…
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC
Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15…
Role of pharmacovigilance in innovating and revolutionising healthcare accessibility in India
Dr Pramod Dhembare, Founder and Managing Partner, Fidelity Health Service, traces the role of pharmacovigilance in public…
Gilead Sciences launches Asia Pacific All4LIVER Grant 2021
The grant aims to empower organisations that can help bring liver health, in particular, viral hepatitis, to the forefront of…
High Commissioner of India visits Wockhardt UK
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK…
Emcure Pharma appoints four new directors
The new members’ collective strength across legal, pharma spectrum, policy developments and academics will provide additional…
Alembic Pharma Q1 net profit declines to Rs 165 cr
The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic…
Biocon Biologics and Adagio Therapeutics to develop antibody treatment for COVID-19
Biocon Biologics to manufacture and commercialise a broadly neutralising antibody for India and select emerging markets
US FDA approves Shingrix to prevent shingles in immuno-compromised adults
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA…
BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India
Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy…
Sun Pharma and Cassiopea SpA sign license and supply agreements for Winlevi
Winlevi is expected to be available in the US in Q4 calendar 2021